Amersham Pharmacia Biotech to supply Progenesis

Nonlinear Dynamics Ltd, a leading provider of bioinformatics solutions, announces that Amersham Pharmacia Biotech (APBiotech) has signed a non-exclusive distributor agreement for sales of Nonlinear's Progenesis™ 2D electrophoresis image analysis software.

Progenesis is a "hands-free" automated image analysis system specifically designed for researchers using 2D gel electrophoresis for their high-throughput proteomics projects. By automating the analysis stage of 2D gel electrophoresis, Progenesis has smashed the bottleneck traditionally associated with this widely used and effective method for protein expression studies. Progenesis complements and supports APBiotech's Ettan™ proteomics research platform.

Will Dracup, Managing Director and founder of Nonlinear Dynamics, said: "We already have an extremely good working relationship with Amersham Pharmacia Biotech since they sell our standard products under the ImageMaster™ name." He added, "This new venture drives our collaboration forward to a new phase, allowing us to utilise our combined expertise and respond to the demanding needs of the proteomics market place."

Neil Cook, Vice President of Drug Discovery, APBiotech, said: "With more than 40 years of experience in the protein sciences, APBiotech has built a portfolio of technologies specifically for high-throughput proteomics, and Progenesis is an excellent addition to that portfolio."

Nonlinear Dynamics (Nonlinear) is a privately owned software development company providing Bioinformatics solutions. The company has developed the Phoretix range since 1989, which concentrates on the core technologies of 1D and 2D electrophoresis and high-throughput arrays. Progenesis™ is the first product to emerge from the company's ‘Nonlinear Technology' development resource, the backbone that results in quicker delivery of the most reliable and innovative Life Science software.

Amersham Pharmacia Biotech (APBiotech), the life sciences business of Nycomed Amersham plc, is a leading global provider of biotechnology systems, products and services for research into genes and proteins, for the discovery and development of drugs and for the manufacture of biopharmaceuticals. The customers for APBiotech's products and technology are pharmaceutical and biotechnology companies and research and academic institutions in North America, Europe, Latin America and Asia.

Source: Nonlinear Dynamics Limited

Subscribe to our free e-mail newsletter.

Click for a free Buyer's Guide listing.